124 related articles for article (PubMed ID: 11019921)
1. HLA-B44 subtyping in the Catalan population using reference strand mediated conformation analysis. Implications for the selection of unrelated bone marrow donors.
Gallardo D; Aróstegui JI; Rodríguez-Luaces M; Querol S; González JR; García-López J; Grañena A
Tissue Antigens; 2000 Aug; 56(2):173-7. PubMed ID: 11019921
[TBL] [Abstract][Full Text] [Related]
2. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.
Keever CA; Leong N; Cunningham I; Copelan EA; Avalos BR; Klein J; Kapoor N; Adams PW; Orosz CG; Tutschka PJ
Bone Marrow Transplant; 1994 Jul; 14(1):137-45. PubMed ID: 7951101
[TBL] [Abstract][Full Text] [Related]
3. HLA-B44 subtyping in a Spanish population: further evidence of Caucasian population diversity.
Santos S; Vicario JL; Merino JL; Balas A
Tissue Antigens; 1997 Feb; 49(2):124-8. PubMed ID: 9062967
[TBL] [Abstract][Full Text] [Related]
4. HLA-B44 allele frequencies and haplotypic associations in three European populations.
Vidan-Jeras B; Breur-Vriesendorp B; Bohinjec M; Jeannet M; Roosnek E; Tiercy JM
Eur J Immunogenet; 1997 Oct; 24(5):335-43. PubMed ID: 9442801
[TBL] [Abstract][Full Text] [Related]
5. Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors.
Tiercy JM; Djavad N; Rufer N; Speiser DE; Jeannet M; Roosnek E
Hum Immunol; 1994 Nov; 41(3):207-15. PubMed ID: 7868376
[TBL] [Abstract][Full Text] [Related]
6. HLA-B44 subtypes and the chance of finding HLA compatible donor/recipient pairs for bone marrow transplantation: a haplotype study of 303 Italian families.
Mattiuz PL; Di Paolo E; Fossombroni V; Menicucci A; Pradella F; Porfirio B; Rombolà G
Tissue Antigens; 1997 Dec; 50(6):602-9. PubMed ID: 9458113
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 250 HLA-B44 genotypes in European Caucasoids: high diversity and preferential ABCDRB1 associations in B*4402, B*4403, and B*4405 haplotypes.
Tiercy JM
Tissue Antigens; 2005 May; 65(5):429-36. PubMed ID: 15853897
[TBL] [Abstract][Full Text] [Related]
8. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
Herman J; Jongeneel V; Kuznetsov D; Coulie PG
Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
[TBL] [Abstract][Full Text] [Related]
9. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
11. HLA-B44-restricted minor antigen.
Tiercy JM; Jeannet M; Roosnek E
Transplantation; 1995 Jul; 60(1):113-4. PubMed ID: 7624936
[No Abstract] [Full Text] [Related]
12. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs. Analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectrofocusing, and HLA oligotyping.
Rufer N; Breur-Vriesendorp BS; Tiercy JM; Slavcev AS; Lardy NM; Francis P; Kressig R; Speiser DE; Helg C; Chapuis B
Hum Immunol; 1993 Nov; 38(3):235-9. PubMed ID: 8106284
[TBL] [Abstract][Full Text] [Related]
13. HLA-A and -B alleles in cornea donors as risk factors for graft rejection.
Creemers PC; Kahn D; Hill JC
Transpl Immunol; 1999 Mar; 7(1):15-8. PubMed ID: 10375073
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*4413 identified in a UK Caucasoid potential bone marrow donor.
Cox ST; McWhinnie A; Prokupek B; Madrigal JA; Little AM
Tissue Antigens; 2000 Feb; 55(2):185-7. PubMed ID: 10746795
[TBL] [Abstract][Full Text] [Related]
15. A new HLA-B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5.
Dubois V; Tiercy JM; Labonne MP; Dormoy A; Gebuhrer L
Tissue Antigens; 2004 Feb; 63(2):173-80. PubMed ID: 14705988
[TBL] [Abstract][Full Text] [Related]
16. Characterization and distribution of HLA-B*5002 in a Spanish population sample.
Balas A; Santos S; García-Sánchez F; Lillo R; Merino L; Vicario JL
Tissue Antigens; 1998 Aug; 52(2):183-6. PubMed ID: 9756408
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*44 allele frequencies and haplotypic associations in Koreans.
Song EY; Whang DH; Hur M; Kang SJ; Han KS; Park MH
Hum Immunol; 2001 Oct; 62(10):1142-7. PubMed ID: 11600222
[TBL] [Abstract][Full Text] [Related]
18. HLA-A, -B, -C, -DRB1, and -DQB1 allele and haplotype frequencies: An analysis of umbilical cord blood units at the Barcelona Cord Blood Bank.
Enrich E; Campos E; Martorell L; Herrero MJ; Vidal F; Querol S; Rudilla F
HLA; 2019 Oct; 94(4):347-359. PubMed ID: 31353832
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors.
Vitale C; Pitto A; Benvenuto F; Ponte M; Bellomo R; Frassoni F; Mingari MC; Bacigalupo A; Moretta L
Hematol J; 2000; 1(2):136-44. PubMed ID: 11920181
[TBL] [Abstract][Full Text] [Related]
20. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.
Herman J; van der Bruggen P; Luescher IF; Mandruzzato S; Romero P; Thonnard J; Fleischhauer K; Boon T; Coulie PG
Immunogenetics; 1996; 43(6):377-83. PubMed ID: 8606058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
